320 W 10th Ave
Columbus, OH 43210
Assistant Professor - Practice, Hospital Medicine
Physician, FGP-Hospital Medicine
|1997||B.A., Colgate University|
|2005||D.O., New York College of Osteopathic Medicine (NYCOM) of New York Institute of Technology (NYIT)|
Upton-Rice,M,N; Cudkowicz,M,E; Mathew,R,K; Brown,R,H. "Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice." ANNALS OF NEUROLOGY. Vol. 45, no. 3. (March 1999.): 413-414.
Upton-Rice,M,N; Cudkowicz,M,E; Warren,L; Mathew,R,K; Ren,J,M; Finklestein,S,P; Brown,R,H. "Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis." ANNALS OF NEUROLOGY. Vol. 46, no. 6. (December 1999.): 934-934.
Shefner JM, Brown RH Jr, Cole D, Chaturvedi P, Schoenfeld D, Pastuszak K, Mathew RK, Upton-Rice M, Cudkowicz ME. "Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations." Neurology. Vol. 57, no. 10. (November 2001.): 1857-1861.
Cudkowicz ME, Pastuszak KA, Sapp PC, Mathew RK, Leahy J, Pasinelli P, Francis JW, Jiang D, Andersen JK, Brown RH Jr. "Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity." Neurology. Vol. 59, no. 5. (September 2002.): 729-734.
Quraishi MB, Mathew RK, Lowes A, Bashir CM, Markert RJ. "Venous Thromboembolism Prophylaxis and the Impact of Standardized Guidelines: Is a Computer-Based Approach Enough?." Journal of Clinical Outcome Management. Vol. 18, no. 11. (November 2011.): 505-512.
Liston BW, Barr J; Heacock A; Ganith R, Patel C, Allen J, Catignani K, Matthew R, Wenger A, Tartaglia K. "Cases from The Ohio State University Medical Center." ACP Hospitalist. Vol. 2, no. 2. (August 2013.): 2-.